Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Glucagon-like peptide-1 receptor activation in the ventral tegmental area attenuates cocaine seeking in rats
Nicole S. Hernandez, Kelsey Y. Ige, Elizabeth G. Mietlicki‐Baase, et al.
Neuropsychopharmacology (2018) Vol. 43, Iss. 10, pp. 2000-2008
Open Access | Times Cited: 92

Showing 1-25 of 92 citing articles:

The role of glucagon‐like peptide 1 (GLP‐1) in addictive disorders
Mette Kruse Klausen, Morgane Thomsen, Gitta Wörtwein, et al.
British Journal of Pharmacology (2021) Vol. 179, Iss. 4, pp. 625-641
Open Access | Times Cited: 110
The glucagon-like peptide-1 (GLP-1) analogue semaglutide reduces alcohol drinking and modulates central GABA neurotransmission
Vicky Chuong, Mehdi Farokhnia, Sophia Khom, et al.
JCI Insight (2023) Vol. 8, Iss. 12
Open Access | Times Cited: 84
GLP-1: Molecular mechanisms and outcomes of a complex signaling system
Nicholas K. Smith, Troy A. Hackett, Aurelio Galli, et al.
Neurochemistry International (2019) Vol. 128, pp. 94-105
Open Access | Times Cited: 118
Can GLP-1 Be a Target for Reward System Related Disorders? A Qualitative Synthesis and Systematic Review Analysis of Studies on Palatable Food, Drugs of Abuse, and Alcohol
Candan Yasemin Eren, Arya Yigit, Ramazan Efe Dogruoz, et al.
Frontiers in Behavioral Neuroscience (2021) Vol. 14
Open Access | Times Cited: 72
The therapeutic potential of glucagon-like peptide-1 for persons with addictions based on findings from preclinical and clinical studies
Elisabet Jerlhag
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 37
Liraglutide restores impaired associative learning in individuals with obesity
Ruth Hanßen, Lionel Rigoux, Bojana Kuzmanovic, et al.
Nature Metabolism (2023) Vol. 5, Iss. 8, pp. 1352-1363
Open Access | Times Cited: 24
IUPHAR review – Glucagon-like peptide-1 (GLP-1) and substance use disorders: An emerging pharmacotherapeutic target
Nicolaus Bruns, Elizabeth H. Tressler, Leandro F. Vendruscolo, et al.
Pharmacological Research (2024) Vol. 207, pp. 107312-107312
Open Access | Times Cited: 12
GLP-1 programs the neurovascular landscape
Bandy Chen, Xiaofei Yu, Claudia Horvath-Diano, et al.
Cell Metabolism (2024) Vol. 36, Iss. 10, pp. 2173-2189
Closed Access | Times Cited: 10
An analysis on the role of glucagon-like peptide-1 receptor agonists in cognitive and mental health disorders
Riccardo De Giorgi, Ana Ghenciulescu, Oliwia Dziwisz, et al.
Nature Mental Health (2025)
Open Access | Times Cited: 1
An endogenous GLP-1 circuit engages VTA GABA neurons to regulate mesolimbic dopamine neurons and attenuate cocaine seeking
R. Merkel, Nicole S. Hernandez, Vanessa Weir, et al.
Science Advances (2025) Vol. 11, Iss. 9
Open Access | Times Cited: 1
Gut-brain axis and addictive disorders: A review with focus on alcohol and drugs of abuse
Elisabet Jerlhag
Pharmacology & Therapeutics (2018) Vol. 196, pp. 1-14
Open Access | Times Cited: 79
A novel mouse model of glucagon‐like peptide‐1 receptor expression: A look at the brain
Devon L. Graham, Heather Durai, Taylor S. Trammell, et al.
The Journal of Comparative Neurology (2020) Vol. 528, Iss. 14, pp. 2445-2470
Open Access | Times Cited: 56
The role of glia in the physiology and pharmacology of glucagon‐like peptide‐1: implications for obesity, diabetes, neurodegeneration and glaucoma
Qi N. Cui, Lauren M. Stein, Samantha M. Fortin, et al.
British Journal of Pharmacology (2021) Vol. 179, Iss. 4, pp. 715-726
Open Access | Times Cited: 47
Effects of dulaglutide on alcohol consumption during smoking cessation
Leila Probst, Sophie Monnerat, D. Vogt, et al.
JCI Insight (2023) Vol. 8, Iss. 22
Open Access | Times Cited: 21
Insight into the role of the gut-brain axis in alcohol-related responses: Emphasis on GLP-1, amylin, and ghrelin
Maximilian Tufvesson‐Alm, Olesya T. Shevchouk, Elisabet Jerlhag
Frontiers in Psychiatry (2023) Vol. 13
Open Access | Times Cited: 20
The emerging role of glucagon-like peptide 1 in binge eating
Katherine N. Balantekin, Martin J. Kretz, Elizabeth G. Mietlicki‐Baase
Journal of Endocrinology (2024) Vol. 262, Iss. 1
Open Access | Times Cited: 7
Targeting GLP-1 receptors to reduce nicotine use disorder: Preclinical and clinical evidence
Rae J. Herman, Heath D. Schmidt
Physiology & Behavior (2024) Vol. 281, pp. 114565-114565
Open Access | Times Cited: 6
The Impact of GLP-1 Receptor Agonists (GLP-1 RAs) on Mental Health: A Systematic Review
Silvia Tempia Valenta, Alba Nicastri, Federica Perazza, et al.
Current Treatment Options in Psychiatry (2024)
Closed Access | Times Cited: 6
Brain region specific glucagon-like peptide-1 receptors regulate alcohol-induced behaviors in rodents
Daniel Vallöf, Aimilia Lydia Kalafateli, Elisabet Jerlhag
Psychoneuroendocrinology (2019) Vol. 103, pp. 284-295
Open Access | Times Cited: 52
Activation of GLP-1 receptors attenuates oxycodone taking and seeking without compromising the antinociceptive effects of oxycodone in rats
Yafang Zhang, Michelle W. Kahng, Jaclynn A. Elkind, et al.
Neuropsychopharmacology (2019) Vol. 45, Iss. 3, pp. 451-461
Open Access | Times Cited: 52
Parallels and Overlap: The Integration of Homeostatic Signals by Mesolimbic Dopamine Neurons
Ted M. Hsu, James E. McCutcheon, Mitchell F. Roitman
Frontiers in Psychiatry (2018) Vol. 9
Open Access | Times Cited: 51
Glucagon-Like Peptide-1 Receptor Agonist Treatment Does Not Reduce Abuse-Related Effects of Opioid Drugs
Annika Billefeld Bornebusch, Anders Fink‐Jensen, Gitta Wörtwein, et al.
eNeuro (2019) Vol. 6, Iss. 2, pp. ENEURO.0443-18.2019
Open Access | Times Cited: 48
Central GLP-1 receptors: Novel molecular targets for cocaine use disorder
Nicole S. Hernandez, Heath D. Schmidt
Physiology & Behavior (2019) Vol. 206, pp. 93-105
Open Access | Times Cited: 43
Gut peptide regulation of food intake – evidence for the modulation of hedonic feeding
Orla Woodward, Fiona M. Gribble, Frank Reimann, et al.
The Journal of Physiology (2021) Vol. 600, Iss. 5, pp. 1053-1078
Open Access | Times Cited: 33
Metabolic hormone action in the VTA: Reward-directed behavior and mechanistic insights
Caroline E. Geisler, Matthew R. Hayes
Physiology & Behavior (2023) Vol. 268, pp. 114236-114236
Open Access | Times Cited: 16
Page 1 - Next Page

Scroll to top